Cargando…
Polymerized porin as a novel delivery platform for coronavirus vaccine
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seriously threatens human life and health. The correct folding and polymerization of the receptor-binding domain (RBD) protein of coronavirus in Escherichia coli may reduce the cost of SARS-C...
Autores principales: | Yang, Zhongqian, Hua, Liangqun, Yang, Mengli, Li, Weiran, Ren, Zhaoling, Zheng, Xiao, Chen, Haoqian, Long, Qiong, Bai, Hongmei, Huang, Weiwei, Ma, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171476/ https://www.ncbi.nlm.nih.gov/pubmed/35672856 http://dx.doi.org/10.1186/s12951-022-01469-8 |
Ejemplares similares
-
A new personalized vaccine strategy based on inducing the pyroptosis of tumor cells in vivo by transgenic expression of a truncated GSDMD N-terminus
por: He, Jinrong, et al.
Publicado: (2022) -
Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response
por: Long, Qiong, et al.
Publicado: (2022) -
The porin VDAC2 is the mitochondrial platform for Bax retrotranslocation
por: Lauterwasser, Joachim, et al.
Publicado: (2016) -
Membrane fusion and drug delivery with carbon nanotube porins
por: Ho, Nga T., et al.
Publicado: (2021) -
The evolutionary history of mitochondrial porins
por: Young, Matthew J, et al.
Publicado: (2007)